News & Updates
Filter by Specialty:
Cardiac rehabilitation improves short-term outcomes in HF patients
Cardiac rehabilitation is standard for the treatment of heart failure (HF) and yields short-term prognostic benefits, a recent study has found. However, long-term benefits remain uncertain.
Cardiac rehabilitation improves short-term outcomes in HF patients
15 Jan 2022
Pola-R-CHP triumphs over R-CHOP in improving PFS in DLBCL
The combination of polatuzumab vedotin with rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R-CHP) demonstrated a significant improvement in progression-free survival (PFS) over the standard-of-care (SoC) regimen of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with previously untreated diffuse large B-cell lymphoma (DLBCL), according to results of the phase III POLARIX study.
Pola-R-CHP triumphs over R-CHOP in improving PFS in DLBCL
14 Jan 2022
Emphysema increases susceptibility to chronic pulmonary aspergillosis
Among patients with Mycobacterium avium complex pulmonary disease, the risk of chronic pulmonary aspergillosis development and mortality is high in the presence of emphysema, according to a study.
Emphysema increases susceptibility to chronic pulmonary aspergillosis
14 Jan 2022
Young-onset dementia common in Southeast Asia
Young-onset dementia (YOD), particularly the Alzheimer’s type, occurs with high frequency among Southeast Asians, according to data from a memory clinic cohort in Singapore. Furthermore, YOD patients with higher education and those who have late-onset dementia with moderate-to-severe cerebrovascular disease burden exhibit a steeper and faster decline in global cognition.
Young-onset dementia common in Southeast Asia
14 Jan 2022
Psychosis not uncommon in Parkinson’s disease, signals cognitive decline
A significant presence of psychosis exists among patients with Parkinson’s disease (PD) in Singapore, potentially indicating a more rapid cognitive decline and progression of PD severity, reports a study.
